These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 10629554)

  • 1. Expression of Fas and Fas ligand in cutaneous B-cell lymphomas.
    Zoi-Toli O; Meijer CJ; Oudejans JJ; de Vries E; van Beek P; Willemze R
    J Pathol; 1999 Dec; 189(4):533-8. PubMed ID: 10629554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Up-regulation of Fas (APO-1/CD95) ligand and down-regulation of Fas expression in human esophageal cancer.
    Gratas C; Tohma Y; Barnas C; Taniere P; Hainaut P; Ohgaki H
    Cancer Res; 1998 May; 58(10):2057-62. PubMed ID: 9605741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reclassification of 300 primary cutaneous B-Cell lymphomas according to the new WHO-EORTC classification for cutaneous lymphomas: comparison with previous classifications and identification of prognostic markers.
    Senff NJ; Hoefnagel JJ; Jansen PM; Vermeer MH; van Baarlen J; Blokx WA; Canninga-van Dijk MR; Geerts ML; Hebeda KM; Kluin PM; Lam KH; Meijer CJ; Willemze R
    J Clin Oncol; 2007 Apr; 25(12):1581-7. PubMed ID: 17353548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apoptosis and Fas-ligand expression correlate to the histopathological grade of gastric smooth muscle tumors.
    Liu Y; Chen C; Chen C; Hsieh H; Chang C; Shyu J; Yen C; Harn H
    J Surg Res; 2001 Feb; 95(2):92-8. PubMed ID: 11162031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential expression of apoptosis-related proteins in various cellular components of ameloblastomas.
    Luo HY; Yu SF; Li TJ
    Int J Oral Maxillofac Surg; 2006 Aug; 35(8):750-5. PubMed ID: 16690252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. c-FLIP expression in bladder urothelial carcinomas: its role in resistance to Fas-mediated apoptosis and clinicopathologic correlations.
    Korkolopoulou P; Goudopoulou A; Voutsinas G; Thomas-Tsagli E; Kapralos P; Patsouris E; Saetta AA
    Urology; 2004 Jun; 63(6):1198-204. PubMed ID: 15183989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of Fas and Fas-related molecules in human hepatocellular carcinoma.
    Lee SH; Shin MS; Lee HS; Bae JH; Lee HK; Kim HS; Kim SY; Jang JJ; Joo M; Kang YK; Park WS; Park JY; Oh RR; Han SY; Lee JH; Kim SH; Lee JY; Yoo NJ
    Hum Pathol; 2001 Mar; 32(3):250-6. PubMed ID: 11274632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequent loss of Fas expression and function in human lung tumours with overexpression of FasL in small cell lung carcinoma.
    Viard-Leveugle I; Veyrenc S; French LE; Brambilla C; Brambilla E
    J Pathol; 2003 Oct; 201(2):268-77. PubMed ID: 14517844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of CD95 antigen and Bcl-2 protein in non-Hodgkin's lymphomas and Hodgkin's disease.
    Nguyen PL; Harris NL; Ritz J; Robertson MJ
    Am J Pathol; 1996 Mar; 148(3):847-53. PubMed ID: 8774139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The predictive value of bcl-2, bax, bcl-xL, bag-1, fas, and fasL for chemotherapy response in advanced breast cancer.
    Sjöström J; Blomqvist C; von Boguslawski K; Bengtsson NO; Mjaaland I; Malmström P; Ostenstadt B; Wist E; Valvere V; Takayama S; Reed JC; Saksela E
    Clin Cancer Res; 2002 Mar; 8(3):811-6. PubMed ID: 11895913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fas ligand is expressed in normal breast epithelial cells and is frequently up-regulated in breast cancer.
    Müllauer L; Mosberger I; Grusch M; Rudas M; Chott A
    J Pathol; 2000 Jan; 190(1):20-30. PubMed ID: 10640988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of Fas (CD95/APO-1) positivity in patients with primary nodal diffuse large B-cell lymphoma.
    Eser B; Sari I; Canoz O; Altuntas F; Cakmak E; Ozturk A; Ozkan M; Er O; Cetin M; Unal A
    Am J Hematol; 2006 May; 81(5):307-14. PubMed ID: 16628716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased Fas ligand expression by T cells and tumour cells in the progression of actinic keratosis to squamous cell carcinoma.
    Satchell AC; Barnetson RS; Halliday GM
    Br J Dermatol; 2004 Jul; 151(1):42-9. PubMed ID: 15270871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Profiling of apoptosis genes identifies distinct types of primary cutaneous large B cell lymphoma.
    van Galen JC; Hoefnagel JJ; Vermeer MH; Willemze R; Dijkman R; Tensen CP; de Boer WP; Meijer CJ; Oudejans JJ
    J Pathol; 2008 Jul; 215(3):340-6. PubMed ID: 18498125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fas expression in renal cell carcinoma accurately predicts patient survival after radical nephrectomy.
    Sejima T; Morizane S; Hinata N; Yao A; Isoyama T; Saito M; Takenaka A
    Urol Int; 2012; 88(3):263-70. PubMed ID: 22398398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. bcl-2 protein expression in primary cutaneous large B-cell lymphoma is site-related.
    Geelen FA; Vermeer MH; Meijer CJ; Van der Putte SC; Kerkhof E; Kluin PM; Willemze R
    J Clin Oncol; 1998 Jun; 16(6):2080-5. PubMed ID: 9626207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary cutaneous diffuse large B-cell lymphoma, leg type: clinicopathologic features and prognostic analysis in 60 cases.
    Grange F; Beylot-Barry M; Courville P; Maubec E; Bagot M; Vergier B; Souteyrand P; Machet L; Dalac S; Esteve E; Templier I; Delaporte E; Avril MF; Robert C; Dalle S; Laroche L; Delaunay M; Joly P; Wechsler J; Petrella T
    Arch Dermatol; 2007 Sep; 143(9):1144-50. PubMed ID: 17875875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An immunophenotypic and molecular study of primary large B-cell lymphoma of bone.
    Huebner-Chan D; Fernandes B; Yang G; Lim MS
    Mod Pathol; 2001 Oct; 14(10):1000-7. PubMed ID: 11598170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical profiling based on Bcl-2, CD10 and MUM1 expression improves risk stratification in patients with primary nodal diffuse large B cell lymphoma.
    Muris JJ; Meijer CJ; Vos W; van Krieken JH; Jiwa NM; Ossenkoppele GJ; Oudejans JJ
    J Pathol; 2006 Apr; 208(5):714-23. PubMed ID: 16400625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. c-FLIP expression in colorectal carcinomas: association with Fas/FasL expression and prognostic implications.
    Korkolopoulou P; Saetta AA; Levidou G; Gigelou F; Lazaris A; Thymara I; Scliri M; Bousboukea K; Michalopoulos NV; Apostolikas N; Konstantinidou A; Tzivras M; Patsouris E
    Histopathology; 2007 Aug; 51(2):150-6. PubMed ID: 17559541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.